Sofie Deleu

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 4

Top Topics

Aortic Dissection

Squamous Cell Carcinoma

Respiratory Syncytial Virus

Top Venues

Paediatric drugs

This page only lists publications with an associated author ORCID identifier.

Publications

Fernando Claudio Ferrero, Chien-Yu Lin, Johannes Liese, Kleber Giovanni Luz, Tatyana Stoeva, Agnes Nemeth, Manuel Gijón, Christina Calvo, Silvina Natalini Martínez, Teck-Hock Toh, Sofie Deleu, Bohang Chen, Sarah Rusch, Beatriz López Sánchez, Illse Leipoldt, Leen Vijgen, Dymphy Huntjens, Tristan Baguet, Kristi Bertzos, Mohamed Gamil, Marita Stevens, null null
CROCuS, a Phase II Study Evaluating the Antiviral Activity, Clinical Outcomes, and Safety of Rilematovir in Children Aged ≥ 28 Days and ≤ 3 Years with Acute Respiratory Tract Infection Due to Respiratory Syncytial Virus. Paediatric drugs (2024)
Fernando Claudio Ferrero, Chien-Yu Lin, Johannes Liese, Kleber Giovanni Luz, Tatyana Stoeva, Agnes Nemeth, Manuel Gijón, Christina Calvo, Silvina Natalini Martínez, Teck-Hock Toh, Sofie Deleu, Bohang Chen, Sarah Rusch, Beatriz López Sánchez, Illse Leipoldt, Leen Vijgen, Dymphy Huntjens, Tristan Baguet, Kristi Bertzos, Mohamed Gamil, Marita Stevens, null null
CROCuS, a Phase II Study Evaluating the Antiviral Activity, Clinical Outcomes, and Safety of Rilematovir in Children Aged ≥ 28 Days and ≤ 3 Years with Acute Respiratory Tract Infection Due to Respiratory Syncytial Virus. Paediatric drugs 26 (4) (2024)
Fernando Claudio Ferrero, Chien-Yu Lin, Johannes Liese, Kleber Giovanni Luz, Tatyana Stoeva, Agnes Nemeth, Manuel Gijón, Christina Calvo, Silvina Natalini Martínez, Teck-Hock Toh, Sofie Deleu, Bohang Chen, Sarah Rusch, Beatriz López Sánchez, Illse Leipoldt, Leen Vijgen, Dymphy Huntjens, Tristan Baguet, Kristi Bertzos, Mohamed Gamil, Marita Stevens, null null
CROCuS, a Phase II Study Evaluating the Antiviral Activity, Clinical Outcomes, and Safety of Rilematovir in Children Aged ≥ 28 Days and ≤ 3 Years with Acute Respiratory Tract Infection Due to Respiratory Syncytial Virus. Paediatric drugs 26 (4) (2024)
Fernando Claudio Ferrero, Chien-Yu Lin, Johannes Liese, Kleber Giovanni Luz, Tatyana Stoeva, Agnes Nemeth, Manuel Gijón, Christina Calvo, Silvina Natalini Martínez, Teck-Hock Toh, Sofie Deleu, Bohang Chen, Sarah Rusch, Beatriz López Sánchez, Illse Leipoldt, Leen Vijgen, Dymphy Huntjens, Tristan Baguet, Kristi Bertzos, Mohamed Gamil, Marita Stevens, null null
CROCuS, a Phase II Study Evaluating the Antiviral Activity, Clinical Outcomes, and Safety of Rilematovir in Children Aged ≥ 28 Days and ≤ 3 Years with Acute Respiratory Tract Infection Due to Respiratory Syncytial Virus. Paediatric drugs 26 (4) (2024)